- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07804407
Prospective Evaluation of AI Generated History of Present Illness Drafts in the Emergency Department
September 1, 2026 updated by: LEE STEPHEN GYUNG WON, Yonsei University
Prospective Evaluation of Artificial Intelligence-generated History of Present Illness Drafts in the Emergency Department
This single-center prospective observational study evaluates whether an on-premise, large language model-based tool (EDnote) that generates a draft history of present illness (HPI) from real-time transcription of the patient-physician encounter produces documentation of higher quality than conventional physician-written HPI in the emergency department.
The treating physician writes the conventional HPI blinded to the AI draft.
Unedited AI-generated HPI drafts and conventional HPI are compared through blinded review by independent emergency physicians.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephen GW LEE
- Phone Number: 82-2-2228-2678
- Email: leestephengyungwon@yuhs.ac
Study Locations
-
-
Seoul City
-
Seoul, Seoul City, South Korea, 03722
- Recruiting
- Yonsei University Severance Hospital
-
Contact:
- Stephen GW LEE
- Phone Number: 82-2-2228-2678
- Email: leestephengyungwon@yuhs.ac
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult patients presenting to the emergency department of a single tertiary teaching hospital in Korea.
Description
Inclusion Criteria:
- Age ≥19 years; presenting to the emergency department; initial encounter documented with EDnote; verbal consent to study participation.
Exclusion Criteria:
- Cardiac arrest; limited ability of both patient and guardian to communicate verbally; refusal of participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ED patients with EDnote-assisted initial encounter
Adult emergency department patients whose initial encounter was recorded by EDnote.
While the treating physician conducts usual care and writes the conventional HPI, EDnote generates an AI HPI draft in the background; the physician remains blinded to the draft.
Both HPIs are evaluated by independent raters blinded to document source.
|
On-premise large language model-based tool that transcribes the patient-physician encounter in real time and generates an unedited HPI draft.
The treating physician is blindedto the AI HPI draft.
HPI written by the treating emergency physician according to usual practice, blinded to the EDnote-generated HPI draft.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Encounter-level clinical fact capture rate
Time Frame: At blinded review, within 6 months after each index ED visit
|
At blinded review, within 6 months after each index ED visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Modified PDQI-9 score
Time Frame: At blinded review, within 6 months after each index ED visit
|
At blinded review, within 6 months after each index ED visit
|
|
AI HPI draft generation time
Time Frame: At index ED visit
|
At index ED visit
|
|
Rater identification of document authorship (AI vs. physician-written)
Time Frame: At blinded review, within 6 months after each index ED visit
|
At blinded review, within 6 months after each index ED visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
September 1, 2026
First Submitted That Met QC Criteria
September 1, 2026
First Posted (Actual)
September 4, 2026
Study Record Updates
Last Update Posted (Actual)
September 4, 2026
Last Update Submitted That Met QC Criteria
September 1, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2026-0708
- C-2026-0010 (Other Grant/Funding Number: Severance Hospital Research fund for Clinical excellence(SHRC))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be shared due to concerns regarding patient privacy and personal information protection.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.